Literature DB >> 20724699

Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

Silvio Antoniak1, Mauricio Rojas, Denise Spring, Tara A Bullard, Edward D Verrier, Burns C Blaxall, Nigel Mackman, Rafal Pawlinski.   

Abstract

OBJECTIVE: To investigate the effect of protease-activated receptor (PAR) 2 deficiency on ischemia/reperfusion (I/R) injury-induced infarct size, inflammation, heart remodeling, and cardiac function. METHODS AND
RESULTS: PAR-2 signaling enhances inflammation in different diseases. The effect of PAR-2 deficiency in cardiac I/R injury is unknown. PAR-2(-/-) mice and wild-type littermates were subjected to 30 minutes of ischemia and up to 4 weeks of reperfusion. Infarct size, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinases, and inflammatory gene expression were assessed 2 hours after reperfusion. Changes in heart size and function were measured by echocardiography up to 4 weeks after reperfusion. Infarct size was significantly reduced in hearts of PAR-2(-/-) mice compared with wild-type littermates. In addition, oxidative/nitrative stress, phosphorylation of mitogen-activated protein kinase, and expression of proinflammatory genes were significantly attenuated in injured hearts of PAR-2(-/-) mice. Finally, PAR-2(-/-) mice were protected from postinfarction remodeling and showed less impairment in heart function compared with wild-type littermates up to 4 weeks after I/R injury.
CONCLUSIONS: PAR-2 deficiency reduces myocardial infarction and heart remodeling after I/R injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20724699      PMCID: PMC2959126          DOI: 10.1161/ATVBAHA.110.213280

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  59 in total

Review 1.  Inflame my heart (by p38-MAPK).

Authors:  Angela Clerk; Peter H Sugden
Journal:  Circ Res       Date:  2006-09-01       Impact factor: 17.367

2.  Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease.

Authors:  Amir Afkhami-Goli; Farshid Noorbakhsh; Avril J Keller; Nathalie Vergnolle; David Westaway; Jack H Jhamandas; Patricia Andrade-Gordon; Morley D Hollenberg; Hosseinali Arab; Richard H Dyck; Christopher Power
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

3.  Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.

Authors:  John H Boyd; Sumeet Mathur; Yingjin Wang; Ryon M Bateman; Keith R Walley
Journal:  Cardiovasc Res       Date:  2006-09-23       Impact factor: 10.787

4.  Activation of mouse protease-activated receptor-2 induces lymphocyte adhesion and generation of reactive oxygen species.

Authors:  S Y Lim; G M Tennant; S Kennedy; C L Wainwright; K A Kane
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

5.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

6.  Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.

Authors:  Ling Tao; Erhe Gao; Xiangying Jiao; Yuexing Yuan; Shuzhuang Li; Theodore A Christopher; Bernard L Lopez; Walter Koch; Lawrence Chan; Barry J Goldstein; Xin L Ma
Journal:  Circulation       Date:  2007-03-05       Impact factor: 29.690

7.  PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts.

Authors:  Rong Jiang; Amanda Zatta; Hajime Kin; Ningping Wang; James G Reeves; James Mykytenko; Jeremiah Deneve; Zhi-Qing Zhao; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-08-24       Impact factor: 4.733

8.  Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy.

Authors:  Rafal Pawlinski; Michael Tencati; Craig R Hampton; Tetsuro Shishido; Tara A Bullard; Liam M Casey; Patricia Andrade-Gordon; Matthias Kotzsch; Denise Spring; Thomas Luther; Jun-ichi Abe; Timothy H Pohlman; Edward D Verrier; Burns C Blaxall; Nigel Mackman
Journal:  Circulation       Date:  2007-10-29       Impact factor: 29.690

9.  Mast cell deficient W/Wv mice have lower serum IL-6 and less cardiac tissue necrosis than their normal littermates following myocardial ischemia-reperfusion.

Authors:  K Bhattacharya; K Farwell; M Huang; D Kempuraj; J Donelan; D Papaliodis; M Vasiadi; T C Theoharides
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Jan-Mar       Impact factor: 3.219

10.  Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways.

Authors:  Farisa Syeda; Jennifer Grosjean; Rebecca A Houliston; Rosemary J Keogh; Tom D Carter; Ewa Paleolog; Caroline P D Wheeler-Jones
Journal:  J Biol Chem       Date:  2006-02-08       Impact factor: 5.157

View more
  27 in total

1.  Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.

Authors:  Leila M Sevigny; Karyn M Austin; Ping Zhang; Shogo Kasuda; Georgios Koukos; Sheida Sharifi; Lidija Covic; Athan Kuliopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-22       Impact factor: 8.311

2.  Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.

Authors:  Silvio Antoniak; Kohei Tatsumi; Clare M Schmedes; Steven P Grover; Rafal Pawlinski; Nigel Mackman
Journal:  J Mol Cell Cardiol       Date:  2018-08-10       Impact factor: 5.000

Review 3.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

4.  Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.

Authors:  Silvio Antoniak; Jessica C Cardenas; Laura J Buczek; Frank C Church; Nigel Mackman; Rafal Pawlinski
Journal:  Cardiology       Date:  2016-11-24       Impact factor: 1.869

5.  Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor.

Authors:  C-H Yeh; T-P Chen; Y-C Wang; S-W Fang; T-C Wun
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

Review 6.  Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?

Authors:  Melissa L Martin; Burns C Blaxall
Journal:  J Cardiovasc Transl Res       Date:  2012-09-27       Impact factor: 4.132

7.  PAR-2 triggers placenta-derived protease-induced altered VE-cadherin reorganization at endothelial junctions in preeclampsia.

Authors:  Y Gu; L J Groome; J S Alexander; Y Wang
Journal:  Placenta       Date:  2012-07-26       Impact factor: 3.481

8.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

9.  Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.

Authors:  Alice Weithauser; Peter Bobbert; Silvio Antoniak; Andreas Böhm; Bernhard H Rauch; Karin Klingel; Konstantinos Savvatis; Heyo K Kroemer; Carsten Tschope; Andrea Stroux; Heinz Zeichhardt; Wolfgang Poller; Nigel Mackman; Heinz-Peter Schultheiss; Ursula Rauch
Journal:  J Am Coll Cardiol       Date:  2013-07-17       Impact factor: 24.094

Review 10.  Mechanisms and consequences of inflammatory signaling in the myocardium.

Authors:  Jihyun Ahn; Jaetaek Kim
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.